Focus on Green Growth and Environmental Sustainability Drives the Global Market for Marine Biotechnology, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Marine Biotechnology markets. Global market for Marine Biotechnology is projected to reach US$4.9 billion by 2018, driven by increased investments in marine biotechnology research, and growing demand for marine ingredients in food, agriculture and cosmetic industries.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Marine Biotechnology: A Global Strategic Business Report

San Jose, California (PRWEB) November 15, 2013

Follow us on LinkedIn – The field of marine biotechnology holds promising potential to harness the vast biodiversity of life in oceans to develop environmentally sustainable products such as cosmetics, pharmaceuticals, fine chemicals, nutritional supplements, and agrichemicals. By studying marine organisms and resources, marine biotechnology seeks to provide potential solutions to address challenges related to food security, healthcare, industrial activities, environmental sustainability and preservation of marine resources. Growth in the industry is driven by rising consumer needs, which cannot be addressed by terrestrial resources alone.

Marine biomedicine is expected to play an important role in improving healthcare by assisting researchers in exploring new compounds and materials with potent uses in preventive therapeutics, personal care, nutraceuticals and health products. In the industrial sector, the technology flaunts the potential to help scientists develop and engineer non-toxic, affordable antifouling technologies, anti-corrosive coatings, and self-cleaning surfaces. Governments across the world are incorporating marine biotechnology into their national innovation and bio-economy strategies. International agreements and conventions are also being forged to provide a framework for conserving marine biodiversity and to facilitate sharing of marine bioresources. Despite the complexities associated with their discovery, marine organisms are being researched using genomic and metagenomic technologies to gain insights into the marine ecosystems’ biodiversity.

As stated by the new market research report on Marine Biotechnology, the United States represents the largest and the fastest growing market worldwide. Strong R&D investments in the country are being directed towards research projects focused on the production of algae-derived bioenergy. Europe is forecast to emerge as a major regional market, given the continent’s yet unexplored and underexploited marine resources. Of special importance is the application of marine biotechnology in the medical sector with the region’s pharmaceutical industry having already developed commercially viable marine derived drugs to treat a range of diseases including cancer. Countries from Asia-Pacific region including China, Japan, Australia, South Korea, India, Vietnam, and Thailand are likely to emerge as key markets of the future.

Bioactive Substances represents the largest product market in the global marine biotechnology market. Health Care/Biotechnology represents the largest application area. Marine-derived drugs are considered as the most successful application of marine biotechnology on a commercial scale. In the drug discovery space, marine microbes are increasingly being researched as potential sources of drugs for treatment of drug-resistant bacterial infections. On the other hand, marine algae are being researched as possible source of biofuel as well as refined high-value chemicals. For achieving sustainable food production, marine biotechnology is being researched for developing new fish breeding and rearing approaches, developing novel feeds, and exploring new opportunities for using marine waste.

Major players covered in the report include Aker BioMarine AS, Aqua Bio Technology ASA, Aquapharm Biodiscovery Ltd., CP Kelco, Cyanotech Corp., FMC Corp., GlycoMar Ltd., Jazz Pharmaceuticals Plc., Lonza Group Ltd., Marinova Pty Ltd., oceanBASIS GmbH, PharmaMar S.A, Prolume Ltd., Pronova BioPharma ASA, Royal DSM N.V, SEPPIC, and Tequesta BioVentures, among others.

The research report titled "Marine Biotechnology: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, R&D initiatives, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe, Asia-Pacific and Rest of World. The report analyzes the global market by end-use applications such as Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Others, and by product segments that include Marine Biomaterials, Marine Bioactive Substances, and Others.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Marine_Biotechnology_Market_Report.asp.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Contact

Attachments